Skip to main content
. 2021 Mar 8;13(3):352. doi: 10.3390/pharmaceutics13030352

Figure 3.

Figure 3

CRISPR-Cas system-based genome editing to combat bacterial infection. When the target genes are ARGs, the CRISPR-Cas system can restore the sensitivity of bacteria to antibiotics, and then the drugs will kill the susceptible bacteria. When the target genes are constitutive genes of the specific resistant bacteria, then the resistant bacteria will be killed. When the target genes are host chromosomal DNA that is cytotoxic to the resistant bacteria, the target cell will die because of the excision of the genome.